Skip to content
Dose-Dependent Von Willebrand Factor Inhibition by Aptamer BB-031 Correlates with Thrombolysis in a Microfluidic Model of Arterial Occlusion
Home
About
Leadership
Board of Directors
Scientific and Clinical Advisory Board
Investment Partners
Science
Approach / Novel RNA Aptamer
Mechanism of Action
Pipeline
Thrombosis
Acute Stroke
Our Solution
Clinical Trials
Publications
News
Featured News
Press Releases
News & Resources
Careers
Baskings Australia
Contact
Privacy Policy
Terms of Use
Sitemap
Hamburger Toggle Menu
